PART 01: Executive summary • Highlights PART 02: Scope of the report • Report overview • Key vendor offerings PART 03: Market research methodology • Research methodology • Economic indicators PART 04: Introduction • Key market highlights PART 05: Technology landscape • Microfluidic systems PART 06: Market landscape • Industry overview • Market size and forecast • Five forces analysis PART 07: Market segmentation by application • End-user applications of microfluidics in healthcare 2015 • End-user applications of microfluidics in healthcare 2020 • In-vitro diagnostics using microfluidics • Pharmaceutical research using microfluidics • Drug delivery devices using microfluidics PART 08: Geographical segmentation • Regional segregation 2015 • Regional segregation 2020 • Americas • EMEA • APAC PART 09: Market drivers • Compact size of microfluidic devices • Growth in lifestyle diseases • Increase in research funding and government participation • Rapid increase in elderly population and age-related diseases • Higher throughput and reduced reaction cost PART 10: Impact of drivers PART 11: Market challenges • High penetration of traditional healthcare equipment • Low margins for companies in the microfluidic value chain • Lack of awareness about microfluidics • Reliability issues PART 12: Impact of drivers and challenges PART 13: Market trends • Use of paper-based microfluidic devices • Growth in POC testing PART 14: Vendor landscape • Competitive scenario PART 15: Key vendors • Abbott Laboratories • Agilent Technologies • Becton Dickinson • Bio-Rad Laboratories • RainDance Technologies • Roche Diagnostics • Siemens Healthcare • Other prominent vendors PART 16: Key recommendations for vendors and investors PART 17: Appendix • List of abbreviations PART 18: Explore Technavio List of Exhibits Exhibit 01: Product offerings Exhibit 02: Steps of a typical microfluidic process Exhibit 03: Market segmentation of microfluidics in healthcare Exhibit 04: Global microfluidic market for healthcare application 2016-2020 ($ billions) Exhibit 05: Five forces analysis Exhibit 06: Percentage segregation of microfluidics for application in healthcare sector 2015 Exhibit 07: Percentage segregation of microfluidics for application in healthcare sector 2020 Exhibit 08: Global microfluidic market for in-vitro diagnostics in healthcare 2015-2020 ($ billions) Exhibit 09: Global microfluidic market in pharmaceutical research for healthcare 2015-2020 ($ billions) Exhibit 10: Global microfluidic market in drug delivery devices for healthcare 2015-2020 ($ millions) Exhibit 11: Geographical share in percentage 2015 Exhibit 12: Geographical share in percentage 2020 Exhibit 13: Global microfluidic market for healthcare application in Americas 2016-2020 ($ billions) Exhibit 14: Global microfluidic market for healthcare application in EMEA 2015-2020 ($ billions) Exhibit 15: Global microfluidic market for healthcare application in APAC 2015-2020 ($ millions) Exhibit 16: Impact of drivers Exhibit 17: Impact of drivers and challenges Exhibit 18: Overview of major players in the global microfluidic market for healthcare application 2015 Exhibit 19: Recent developments: Abbott Laboratories Exhibit 20: Sector performance Exhibit 21: Capital expenditure Exhibit 22: Segment performance Exhibit 23: Capital expenditure Exhibit 24: Siemens Healthcare: Business segmentation Exhibit 25: Recent developments: Siemens Healthcare Exhibit 26: Other prominent vendors

Abbott Laboratories, Agilent Technologies, Becton Dickinson and Company, Bio Rad Laboratories, RainDance Technologies, Roche Diagnostics, Siemens Healthcare GmbH. Biocartis, Biofluidix, Cepheid, Danaher, Fluidigm, Great Basin, Life Technologies, Oxford Nanopore, PerkinElmer, Tear Lab, Thermo Fisher Scientific.